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ABSTRACT Morphine, spin labeled on the 3- or 6-position has been used as the opiate
ligand in a study of the time course of stereospecific opiate binding to intact synap-
tosomes isolated from non-cerebellar rat brain. The broadening of electron spin
resonance lines induced by immobilization of the ligand on binding has been used to
determine the concentration of bound opiate. The stereospecificity of the reaction
was measured by comparing ligand binding in the presence of thousand-fold molar
excesses of dextrorphan or levorphanol. Using both static and flow techniques, the
binding process has been continuously monitored at times greater than 4.8 s after
mixing spin labeled morphine with synaptosomes. It is shown that for this ligand and
receptor preparation, binding takes place primarily during a delayed, abrupt process
whose rate and time of onset are temperature dependent and reflect the presence of
added opiate agonist or antagonist.
INTRODUCTION
We have recently reported certain benefits to be gained from the use of a spin labeled
opiate probe in studies of the opiate receptor (1). Thus, the ability of the technique to
differentiate bound and free probe simultaneously, without sample destruction or
modification, seems to circumvent one great limitation of conventional radiolabel
probe studies of the opiate receptor. Although the potential perturbation of the
molecular behavior of an opiate probe caused by the spin label moiety remains a fea-
ture of the technique which must be kept in mind, its positive features appear well
suited to study the kinetics of the opiate-receptor interaction. In those instances where
opiate-receptor binding vs. time has been determined using radiolabel techniques (2-4),
sampling of the reaction mixture at various incubation times, quenching with cold, and
separating bound from unbound radioactive opiate in the cold have been required.
Difficulties of such procedures have been recently enumerated (5). The immensity of
the task required to obtain extensive details of the binding curve might deter attempts
using conventional methods to obtain the information to be gleaned from such a
study.
The use of a spin labeled opiate probe to study opiate-receptor binding kinetics
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seems a good example of how this biophysical technique can complement conventional
procedures. We have used the displacement procedure (levorphanol vs. dextrorphan)
elaborated by Goldstein et al. (6) to determine both the rate of stereospecific binding
(SSB) of spin labeled morphine (SLM) continuously during incubation in the electron
spin resonance (ESR) cavity and the extent of SSB following incubation. We have
monitored the binding reaction after about 2 min with a static analysis and after 4.8 s
using flow and stop-flow procedures. The results indicate that opiate-receptor binding
is not continuous during an incubation but takes place primarily in one abrupt event
preceded and followed by periods of little binding.
MATERIALS AND METHODS
The two spin labeled morphine analogs, 3-SLM with the 3-(acetamido)-2,2,5,5-tetramethyl- 1-
pyrrolidinyloxyl moiety attached via an ether linkage to the 3-position of morphine (1) and
6-SLM where 4-amino-2,2,6,6-tetramethyl- l-piperidinyloxyl was linked directly to the 6-position
by a halogen displacement reaction with the 6-chloromorphide (7), were prepared and charac-
terized as previously described (1, 7).
Dextrorphan tartrate (d-3-hydroxy-N-methylmorphinan tartrate) and levorphanol tartrate
(I-3-hydroxy-N-methylmorphinan tartrate) were donated by Hoffmann-LaRoche, Nutley, N.J.
Nalorphine HCI was obtained from Applied Science Laboratories, State College, Pa.
Noncerebellar synaptosomes were isolated in the cold as previously described (1, 8) from rat
brain homogenate.' The crude mitochondrial fraction in 0.32 M sucrose was layered on a dis-
continuous gradient (15 ml 0.8 M sucrose, 10 ml 1.2 M sucrose) and centrifuged in a Beckman
SW27 rotor at 100,000 gmax for 90 min (Beckman Instruments, Inc., Fullerton, Calif.). The
band between 0.8 M and 1.2 M sucrose (synaptosomes) was collected, separated, and resus-
pended in 0.32 M sucrose of the desired pH (0.05 M Tris buffer) before determining protein
content (9).
The X-band ESR spectrometer (E-9, Varian Associates, Palo Alto, Calif.) used has been
described elsewhere (1). The magnetic field was modulated at 100 kHz using 2.5 G amplitude
and a microwave power of 16 mW incident on the TE,04 dual cavity. SLM concentrations were
determined using an on-line computer as previously reported (1). Most data were collected
with the field sweep reduced to zero (AH = 0), monitoring relative line amplitude vs. time
(vide infra). Control of sample temperature was accomplished with a variable temperature con-
troller (Varian) coupled to either a variable temperature insertion Dewar (S-821, James F.
Scanlon Co., Solvang, Calif.) or a variable temperature liquid flow cell (Scanlon, S-865).
Samples held in 100 ,ul capillary pipettes were placed in a 3 mm ID quartz ESR tube filled
with a low dielectric oil and suspended in the insertion Dewar. Alternatively (vide infra),
synaptosomes and reagents were pumped independently from reservoirs (0-4°) at 0.23 ml/min
to the controlled temperature mixing chamber and flat cell where they were mixed and observed
at 37°. The sample temperature was continuously monitored by a thermocouple positioned in
the sample stream just outside the cavity sensitive volume. Samples were observed during flow,
4.8 s after mixing or as a function of time after flow was stopped. Incubations were thus per-
formed in the controlled temperature ESR cavity during observation.
For each experiment, a calibration curve relating the change in observed line amplitude
(M = -1 or + 1) to the change in free SLM concentration was determined. It was found that
I In conducting the research described in this report, the investigators adhered to the "Guide for Laboratory
Animal Facilities and Care," as promulgated by the Committee on the Guide for Laboratory Animal Fa-
cilities and Care of the Institute of Laboratory Animal Resources, National Academy of Sciences-National
Research Council.
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the slope of such curves (centimeters per picomole SLM per milliliter) was independent of
the concentration of synaptosomal protein in the range used when 5 mM nalorphine was also
present. The slope could thus be validly determined without synaptosomes. A calibration fac-
tor, k, was then derived from the slope and the synaptosomal protein concentration,
k = [(cm/pmol/ml) (mg/ml)]' = pmol/mg/cm, (1)
for use in expressing line amplitude decreases in terms of picomoles SLM bound per milligram
of synaptosomal protein (vide infra). The calibration factor was dependent on observation
temperature and on the nature of the spin label moiety on morphine. This factor was deter-
mined for stopped flow conditions by mixing SLM concentration standards with 0.32 M sucrose
in the liquid flow cell and measuring absolute line amplitudes during flow and stop-flow
conditions.
RESULTS
Binding Kinetics-Static System
The capillary pipette system just described was used to obtain the binding curve of
3-SLM with synaptosomes shown in Fig. 1. This curve, whose general shape is repre-
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FIGURE 1 Binding curve of 3-SLM with rat brain synaptosomes. Using the static capillary
pipette system described in the text, a sample containing 10.1 mg/mi synaptosomal protein and
1 AiM 3-SLM in 0.32 M sucrose (pH 7.5) was incubated at 37' in the spectrometer cavity and the
relative amplitude of the -1 line maximum was monitored as a function of time. Decreases of
line amplitude are interpreted as due to loss of free 3-SLM by binding (see text). ESR observa-
tion characteristics are described in the text. Inserts A and B show the - line before and after the
incubation depicted. Determination of the binding curve parameters here illustrated (Hadj, mag-
netic field adjustment; abscissa origin; At, time before abrupt decrease, and Ah, total ob-
served line amplitude decrease) is described in the text. After completing the final sweep of the
whole -1 line (insert B), the AH = 0 field location was confirmed to be at the line maximum.
The trace is included in insert B. Relative spectrometer gain, binding curve/inserts = 5/3.2
using 10 and 1 s filter time constants, respectively.
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sentative of those observed in this study when an opiate agonist or antagonist was also
present, was obtained when 20,ul 0.32 M sucrose (pH 7.5) (or "buffer") was combined
with 20,l 3-SLM and 60,ul of a freshly prepared synaptosomal suspension producing
a sample that contained 10.1 mg/ml synaptosomal protein and 1 jiM 3-SLM. Mixing
was carried out at 0 4° and the sample was immediately withdrawn into a capillary
pipette and placed in the spectrometer cavity at 370 with 75 s elapsing between mixing
and beginning the ESR trace. The magnetic field of the spectrometer had been pre-
viously set at the maximum of the M = -1 line of 3-SLM. The time at which the
sample reached 370 (zero time) was marked when the spectrometer detector current
became constant after sample introduction. The final 20 s of this temperature equili-
bration can be seen as the initial amplitude decrease in Fig. 1. The magnetic field was
then adjusted to confirm that the -1 maximum was being monitored. On the trace
illustrated, this adjustment required 1.9 min (usually < 1 min). Consequently, not
until after this time could binding (reduction in line amplitude) be observed.2 After the
sample had been at 370 for about 4 min, the line amplitude began to fall, the rate of
decrease being maximal from 6 to 8 min and no further decrease being noted after 11 to
12 min. Immediately after the 15 min trace, the complete -1 line was scanned and is
depicted in Fig. 1 (insert B). The notation, h(- l)f, is used for this final absolute
line amplitude. The field sweep was again reduced to zero to confirm that the -1 maxi-
mum had in fact been monitored. The AH = 0 trace appears beside the -1 line maxi-
mum. To complete a descriptive picture of the experiment, the trace of a -1 line whose
amplitude equaled the calculated initial line amplitude was also inserted in Fig. 1 (in-
sert A). The initial amplitude or h(- 1)i was determined from h(- l)f and the observed
reduction in line amplitude, Ah (see Fig. 1), using
h(- 1)i = 2 Xh + h(- l)f, (2)
where Ah is normalized for spectrometer gain and doubled to account for the corre-
sponding change in the unseen minimum of the first derivative -1 line. Thus, the
transition we observed was from "A" to "B" with only half of the actual line ampli-
tude changes being monitored.
The portion of the binding curve showing the maximum negative slope was digitized
and fit by a linear least mean squares (LMS) approximation. The LMS line is shown
in Fig. 1. The start of abrupt line amplitude reduction was taken as the intersection
of the LMS line and a similar straight line drawn through the immediately preceding
data and is indicated by the vertical arrow in Fig. 1. The time elapsed at the incuba-
tion temperature before abrupt reduction, At, varied for a given synaptosome prepara-
tion according to added agonist or antagonist concentration, incubation temperature
and the storage time at 0 4° before observation (vide infra).
Curves similar to that shown in Fig. 1 were observed for samples containing 1 mM
dextrorphan, levorphanol, or nalorphine in 0.32 M sucrose (pH 7.5) with synap-
2Reduction in line amplitude and binding are used interchangeably according to hypotheses developed in
Ref. 1.
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TABLE I
STEREOSPECIFIC BINDING OF 3-SLM BY RAT BRAIN SYNAPTOSOMES*
Additive h(-l)ft At§ d[h(- 1)/21/dtII BRt
cm min cm/min pmol/mg/min
Buffer 2.6 6.1 -3.65 ± 0.24 45.2 ± 3.0
Nalorphine (1 mM) 8.5 8.0 - 1.93 : 0.23 23.9 ± 2.8
Dextrorphan (1 mM) 6.6 6.3 -2.95 ± 0.19 36.5 ± 2.4
Levorphanol(l mM) 7.2 6.6 -2.21 +0.17 27.442.1
Sample calculations
SSB = k$[h(- I)f]ev - [h( l)]f dex = 9.68(0.6) = 5.8 pmol/mg
SSBR = BRdeX- BR1e, = 36.5 - 27.4 = 9.1 pmol/mg/min
* Data taken from the experiment described in Fig. 1. Synaptosomal protein concentration was 10.1 mg/ml,
the 3-SLM ligand was 1 MM. These and the additives were suspended in 0.32 M sucrose (pH 7.5; 0.05 M Tris)
with no exogenous sodium being added. The incubation during ESR observation was at 37' and lasted 16
min (see text).
tThe final line amplitude (see Fig. 1 and text).
§ Incubation time before abrupt line amplitude decrease.
|| The maximum slope of the binding curve (see Fig. 2 and text).
SIThe observed binding rate (see text).
tosomes and 3-SLM. The portion of each binding curve containing the abrupt reduc-
tion of line amplitude was fitted by linear LMS approximation and is shown in Fig. 2.
The relative vertical displacement of the curves was determined from h(- i)f values
which are listed in Table I. It can be seen from Fig. 2 that levorphanol and nalorphine
prolonged the time before abrupt binding began and reduced the rate of that binding.
Quantitative binding data are presented in Table I. The h(- l)f values show that
the greatest amount of 3-SLM was bound when both stereospecific and nonspecific
binding (NSB) occurred (buffer). Nalorphine was more effective than levorphanol at
the same concentration (1 mM) in preventing 3-SLM binding. Dextrorphan allowed
more binding than its active enantiomer (levorphanol) but prevented a significant
fraction of the 3-SLM binding occurring in buffer alone. This latter observation sug-
gests that introduction of the spin label moiety at the 3-position may lower the receptor
affinity of the resulting molecule sufficiently that dextrorphan at 1,000 times molar
excess can compete for the receptor even though its affinity is more than three orders
of magnitude lower than that of morphine (2, 10). Final line amplitudes have been
converted to picomoles of 3-SLM bound per milligram of synaptosomal protein using
the relationships:
SSBtotal = k$[h(- l)f]IeV - [h(-l)f]deCx = 5.8 pmol/mg, (3)
where SSBtotal is the stereospecific binding observed after the 16 min incubation illus-
trated in Fig. 1, and k, determined as previously described, was 9.68 pmol/mg per cm
for this study; and,
NSB = TB - SSB, where TB = k[2(Ah)bUf, (4)
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FIGURE 2 Abrupt line amplitude decreases in the presence and absence of SSB. Binding curves
similar to Fig. I were obtained in the presence of 1mM dextrorphan (dex), levorphanol (lev), or
nalorphine (nal) using the procedures described for buffer (buf). That portion of each curve
having maximal negative slope was digitized at 0.1 min intervals and fitted by linear LMS
approximation (see text). The slopes of these curves are tabulated in Table I and used to
determine the rate of SSB. *, Buffer; o, dextrorphan; A, levorphanol; A, nalorphine.
TB or total binding being the sum of NSB and SSB, and (Ah)bUf is as illustrated in
Fig. 1. Nonspecific binding was approximately 139 pmol/mg for this synaptosome
preparation. Thus, at the high concentrations necessary for this spin label investiga-
tion, the NSB/SSB ratio was 23/1, a considerably higher value than previously esti-
mated (1) when levorphanol and dextrorphan were not used to measure SSB.
It must be shown that the abrupt decreases in line amplitude observed in Figs. 1 and
2 are related to SSB and that they represent a significant event in this binding phenome-
non. Findings which substantiate this hypothesis are the variations in the presence of
buffer, dextrorphan, levorphanol, and nalorphine of the abrupt decrease parameters,
(a) incubation time, At, and (b) the rate of line amplitude change, d[h(- 1)/2]dt, and
the correlation of these parameters with the total binding values just calculated. In
buffer, where both NSB and SSB occur, At was 6.1 min and in dextrorphan where
similar binding types should occur, At was 6.3 min. With levorphanol and nalorphine,
this time increased to 6.6 and 8.0 min, respectively. That the time of binding is not the
more important parameter was demonstrated when this experiment was repeated
about 7 h after isolation of synaptosomes which had been stored at 04'. Although
there was still evidence for SSB (2.9 pmol/mg), only 0.7 min separated the four At
values (see Table II).
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The slope of the abrupt line amplitude decrease, on the other hand, was found in
every case investigated to parallel the magnitude of the binding measured after incuba-
tion. The slopes of the lines in Fig. 2 are listed in Table I with standard errors derived
from LMS analysis. Although it is clear that the binding process of which the segment
analyzed is a part probably follows exponential kinetics, a linear regression model fits
this segment about as well as parabolic, power function, or exponential models.
Hence, for simplicity and because of the fairly low signal to noise ratio encountered,
the linear model was adopted. Thus,
BR = 2k{d[h(-1)/2]/dt} pmol/mg/min, (5)
where BR is the binding rate, d[h(- 1)/2]/dt is the LMS slope of the abrupt decrease
(see Figs. 1 and 2) in centimeters per min, 2 is the doubling term, and k is as pre-
viously defined. The standard errors of the slope determination were used to estimate
the minimum error associated with the binding rates listed in Table I. By an argument
analogous to that underlying Eq. 1, these data were used to evaluate stereospecific and
nonspecific binding rates:
SSBR = BRdex - BRIe, = 36.5 - 27.4 = 9.1 pmol/mg/min, (6)
and similarly,
NSBR = BRtotai - SSBR = 45.2 - 9.1 = 36.1 pmol/mg/min, (7)
giving a binding rate ratio (NSBR/SSBR) of 4/1. When binding rates were measured
after synaptosome storage for 7 h, those for buffer and dextrorphan remained approxi-
mately the same but those for nalorphine and levorphanol fell to about half of the
initial values. Although these data imply that some change in the synaptosomal opiate
receptor or in its environment had occurred and inversely affected the rates of SSB
and NSB, reducing the binding rate ratio to unity (see Table II), they are insufficient to
clarify the phenomenon.
Effect of Temperature
When the experiment just described was conducted at a 300 incubation temperature,
both the time of abrupt binding and the binding rates were affected (see Table II).
Binding rate data treated with the Arrhenius relationship,
k'(T) = Aoexp (-Ea/RT) (8)
where AO is a constant, E. is the energy of activation in kilocalories per mole, R is the
Rydberg gas constant, T is the absolute temperature, and BR is used as the rate con-
stant, k', gave the energies of activation listed in Table II. The data suggest that the
nonspecific binding process had no measurable energy of activation whereas about
18 kcal/mol were associated with stereospecific binding. However, because these data
were obtained using synaptosomes stored at 04' for 7-8 h and the extent of SSB had
changed from its initial value (Table I) and because only two temperatures were used
in the derivation, the activation energies must be considered only as order of magni-
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TABLE II
EFFECT OF INCUBATION TEMPERATURE ON STEREOSPECIFIC BINDING*
Additive Temp. h(- l)ft At BRt
OC cm min pmol/mg/min
Buffer 372.4 7.4 42.730 3.0 11.8 33.0
37 10.9 8.0 12.7Nalorphine 30 10.8 12.4 6.8
37 7.9 7.3 13.3Levorphanol 30 7.9
37 7.6 7.5 34.6Dextrorphan 30 7.1 14.8 17.7
TBR SSBR§ NSBR
37 42.7 21.3 21.5
30 33.0 10.9 22.1
Ea(kcal/mol) 6.9 17.8 -0.7
*Continuation of the experiment of Fig. 1 using synaptosomes which had been stored at 0-4°C for 7-8 h. In-
cubations at 30° lasted 20 min. All other conditions as in Fig. 1 and Table 1.
tTabulated values have been corrected for the temperature effect on line amplitude.
§ Data for SSB calculated using nalorphine.
tude estimates. When the incubation temperature was lowered to 20, there was no
change in -1 line amplitude from a buffer sample during a 45 min incubation, sug-
gesting that both SSB and NSB have positive activation energies.
Results with 6-SLM as Ligand
Concurrently with these experiments, similar studies were performed using 6-SLM as
the ligand (not illustrated). While the SSBR was about the same as found with 3-SLM
(cf. 29.4 4 7.2 vs. 21.3 + 3.6 pmol/mg per min for 6-SLM and 3-SLM, respectively),
there was a complete loss of the -1 line in all samples after 10 min at 37°. Even with
5 mM nalorphine, there was no evidence for free 6-SLM after incubation. Thus, the
extent of SSB could not be evaluated. That the binding rates of 6- and 3-SLM varied
in parallel in the presence of the various additives suggests that the same pharmaco-
logic process was being monitored but it is very likely that some process other than
binding contributed to the complete loss of the -1 line. The binding rates with each
additive were greater for 6-SLM. The fact that 6-SLM binding rates in levorphanol
and nalorphine had the greatest increase over 3-SLM data when the ligand should have
remained free, suggests that reduction of the label rather than enhanced binding
was responsible. A high affinity for the receptor would have been expected to
cause the greatest binding rate increase for dextrorphan and buffer samples.
Further data are required for the 6-SLM results to be understood.
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Binding Kinetics-Stop-Flow System
Binding which might have taken place between the time of mixing at 0-4° and
the completion of field adjustment when the samples had been at incubation tem-
perature for 1-2 min, i.e., the "hidden time," could not have been examined with
the static sample system. Hence, in order to confirm that the static results relate
to the actual binding phenomenon, we examined the events taking place in this
hidden time. The flow system previously described was used to introduce 3-SLM
and levorphanol or dextrorphan into the mixing chamber together with synapto-
somes and then to the flat cell at 230,ul/min such that the synaptosomes had been
exposed to the ligand for 4.8 s when the center of the cavity sensitive volume was
reached. Each reactant had been exposed to ambient temperature (200) for about
5 min and to 370 for about 30 s at the time of mixing. Thus, the flow experiment
examined all but the first 4.8 s of the "hidden" time.
The data (not illustrated) revealed no consistent variations in line amplitude
from that during flow until 2 to 3 min after flow had been stopped. When the
mixed sample contained 1 mM dextrorphan and 7.25 mg/ml synaptosomal protein
in 0.32 M sucrose (pH 8.0), there was a slow line amplitude decrease from 2 min to
about 6 min, a rapid decrease from 6 to 7 min and then a slow decline from 10 to
15 min after stop-flow (cf. Fig. 1). Levorphanol at the same concentration prolonged
the onset of abrupt line amplitude decrease until about 8 min and after 9 min following
stop-flow, there was little additional decrease. SSB could first be discerned about
11 min after stop-flow. Discontinuous monitoring precluded determination of binding
rates. Total stereospecific binding calculated as before was about 20.1 pmol/mg after
a 17 min, 370 incubation. Thus, within the limits of experimental error, there was no
evidence for any binding until about 2 min after mixing incubation temperature re-
agents. Since all the static experiments produced on-line real-time data by this time,
their relevance is strengthened. The fact that final line amplitudes, when adjusted for
the amplitude reduction actually observed, gave values for amplitude before binding
(see Eq. 2) which agreed with concentration standards, indicates that only minimal
binding could have occurred in the "hidden" 4.8 s. The nearly four times greater SSB
measured during the stop-flow study at pH 8, 7.25 mg/ml protein is consistent with
results (unpublished) showing that these two experimental conditions are closer to
optimal for spin labeled ligand and synaptosome receptor (pH 8.0, 160/1 ligand to
protein ratio, picomoles per milligram).
DISCUSSION
The events of the stereospecific opiate binding process reported here are probably
inaccessible using conventional radiolabel procedures (see, for example, ref. 5). The
fact that use of radiolabeled antagonists or agonists requires a washing and filtering
step to remove unbound material not only precludes the continuous sampling desired
for a kinetic experiment but also may remove weakly bound material, leave unbound
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radioactive material trapped in cytoplasmic spaces (e.g., refs. 5, 11, 12) or allow the
binding reaction to proceed beyond the nominal sampling time. The curve describing
the time course of 2 nM [3H]dihydromorphine binding to corpus striatum homogenate
obtained by Wong and Horng (3) differs considerably from our results (Fig. 1). At 370,
they found that SSB had reached its half-maximum level in about 3 min. Moreover,
the binding rate appeared constant over this time. There was no evidence for a de-
layed, abrupt binding. Pert and Snyder (2) have reported that 5 nM [3H]naloxone
SSB at 37° to rat brain homogenate reached its half-maximum level after a 2 min
incubation. It is conceivable, then, that the prolonged period prior to an abrupt bind-
ing seen in our study could be due to the modification of the opiate ligand.3 It could
also be considered that the ability of the spin label method to distinguish bound and
free ligand continuously without the possible errors introduced during washing and
filtering may have been sufficient to detect events not previously found.
The principal limitation of the spin label method employed is the comparatively high
ligand concentration required for ESR detection. Thus, the 1 ,uM ligand concentra-
tion used was at least 200 times higher than that below which nonspecific ligand bind-
ing becomes insignificant (10). Consequently, we have used the displacement tech-
nique of Goldstein et al. (6) to distinguish SSB in our system where less than 5% of the
total binding observed was stereospecific. The ratio of NSB/SSB (23/1) observed is
similar to that obtained by Goldstein et al. in earlier studies using a radiolabeled
ligand at a comparable concentration (2 ,uM [3H]levorphanol; NSB/SSB = 49/1) (6).
There have been no previous reports where either the binding rate or activation energy
of SSB has been specifically estimated. Creese et al. (5) have extensively studied the
effect of temperature on agonist vs. antagonist binding after incubation to equilibrium,
but did not specifically consider the activation energy of the binding reaction. The
Q1O of SSB ([3H]naloxone, whole brain homogenate) from 25 to 350 has been reported
to be 1.5 (2) or approximately 7.4 kcal/mol (calculated from Qlo with Eq. 8). The
order of magnitude estimate of SSB activation energy, 18 kcal/mol (Table II), is some-
what higher as might be expected for a ligand with increased bulk and decreased re-
ceptor affinity.
The characteristic shape of the binding curves we have observed seems consistent
with the concept that the opiate receptor has two conformations, agonist and antago-
nist, which are in equilibrium and that the position of the equilibrium may be shifted
by factors such as sodium ion concentration, temperature, and the presence of agonists
or antagonists (4, 5, 13, 14). In isolated synaptosomes, the equilibrium might be
shifted toward the "antagonist" conformation. Initial binding of the ligand to the
few "agonist" receptors might shift the equilibrium toward that conformation, pre-
cipitating the binding cascade observed. The lower affinity of the spin labeled ligand
3Similar very slow initial binding has apparently been observed using standard procedures (i.e., radiolabeled
ligand, washing and filtration) giving much higher temperature coefficients than for simple binding interac-
tions and suggesting that a conformation change of some sort is required as part of the binding process.
Such conformation change might be related to some kind of aggregation of receptors in the fluid membrane
as is now suggested for various antibody receptors. (A. Goldstein, 1976, personal communication).
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may expand the time scale of the phenomenon, exaggerating events which occur before
the first sampling in a radiolabeled ligand experiment.
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